Trials / Conditions / Idiopathic Growth Hormone Deficiency
Idiopathic Growth Hormone Deficiency
3 registered clinical trials studyying Idiopathic Growth Hormone Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children NCT03223025 | Cinnagen | Phase 3 |
| Completed | A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 NCT02173821 | Ferring Pharmaceuticals | Phase 3 |
| Completed | First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone D NCT01419249 | Merck KGaA, Darmstadt, Germany | Phase 4 |